MOYOM Biotech secures a financing round from Cathay Capital to accelerate global growth in regenerative aesthetics. This investment supports the company's next phase of development.
Round Type
Venture
ShanghaiManufacturingBiotechnologyHealth CareInvestors
Description
MOYOM Biotech, specializing in regenerative aesthetic biomaterials, has completed a new financing round from the Cathay Consumer Co-Creation Fund. This investment will support its growth and innovation in the beauty and medical aesthetics industry. Founded in 2018, MOYOM focuses on nanomedical biomaterials and implantable medical devices. The financing marks an important milestone in the company's development.
Quick answer
MOYOM Biotech raised an undisclosed amount in a funding round, dated September 28, 2026. Investors: Cathay Consumer Co-Creation Fund. MOYOM Biotech is based in Shanghai, China.
- How much did MOYOM Biotech raise?
- MOYOM Biotech raised an undisclosed amount in a funding round on September 28, 2026.
- Who invested in MOYOM Biotech?
- Cathay Consumer Co-Creation Fund is named as investors in this round.
- What does MOYOM Biotech do?
- MOYOM Biotech develops regenerative aesthetic biomaterials and absorbable implantable medical devices.
- Where is MOYOM Biotech based and how big is it?
- MOYOM Biotech is based in Shanghai, China.
Source: Fundz verified event record.
Who else raised in Manufacturing and Biotechnology around the same time
Companies in the same sectors as MOYOM Biotech that raised within 45 days of this round, from Fundz verified event records.
- Mosaic Intelligence Labs raised $47M (Seed) on November 10, 2026.
- IM Cannabis Corp raised $1.2M (Convertible Note) on November 4, 2026.
- MyoPax raised an undisclosed amount (Pre-Seed) on November 4, 2026.
- Picard Medical raised $1.2M (Funding Round) on November 3, 2026.
- Blue Arbor Technologies raised $11M (Series A) on October 28, 2026.
- Endovia Health Sciences, Inc. raised $135M (Post-IPO Equity) on October 27, 2026.
Who to call at MOYOM Biotech, and when
A new round usually means MOYOM Biotech is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day MOYOM Biotech raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at MOYOM Biotech, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at MOYOM Biotech. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment MOYOM Biotech raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
MOYOM Biotech raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.